Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
13.18
-0.14 (-1.05%)
Jun 18, 2026, 3:00 PM CST
SHA:688658 Revenue
Youcare Pharmaceutical Group had revenue of 556.04M CNY in the quarter ending March 31, 2026, a decrease of -3.70%. This brings the company's revenue in the last twelve months to 2.42B, down -28.48% year-over-year. In the year 2025, Youcare Pharmaceutical Group had annual revenue of 2.45B, down -35.30%.
Revenue (ttm)
2.42B
Revenue Growth
-28.48%
P/S Ratio
2.42
Revenue / Employee
844.86K
Employees
2,870
Market Cap
5.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.45B | -1.33B | -35.30% |
| Dec 31, 2024 | 3.78B | -415.42M | -9.90% |
| Dec 31, 2023 | 4.20B | -345.64M | -7.61% |
| Dec 31, 2022 | 4.54B | -423.78M | -8.53% |
| Dec 31, 2021 | 4.97B | 626.78M | 14.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Suzhou Fengbei Biotech Stock | 3.61B |
| Anhui Huaheng Biotechnology | 2.95B |
| Xiangxue Pharmaceutical | 1.53B |
| Chengdu Kanghua Biological Products | 1.20B |
| Wuhan Keqian Biology Co.,Ltd | 932.09M |
| Acrobiosystems | 887.21M |
| Zhejiang Ausun Pharmaceutical | 794.80M |
| Jiangsu Aidea Pharmaceutical Group | 699.33M |